The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Phenylketonuria Treatment-Global Market Insights and Sales Trends 2025

Phenylketonuria Treatment-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1861534

No of Pages : 85

Ask Your Query

Synopsis

This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.

This report mainly focuses on the treatment for PKU.

The global Phenylketonuria Treatment market size is expected to reach US$ 1741.5 million by 2029, growing at a CAGR of 3.8% from 2023 to 2029. The market is mainly driven by the significant applications of Phenylketonuria Treatment in various end use industries.

The expanding demands from the Hospital Pharmacies, Drug Stores, Online Pharmacies and Pediatric Clinics, are propelling Phenylketonuria Treatment market. Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dietary Supplement segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs.

However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Phenylketonuria Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Phenylketonuria Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Phenylketonuria Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Phenylketonuria Treatment sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Phenylketonuria Treatment covered in this report include American Gene Technologies, Dimension Therapeutics, BioMarin Pharmaceutical, Synthetic Biologics, Codexis, SOM Innovation Biotech, Daiichi Sankyo and Erytech Pharma, etc.

The global Phenylketonuria Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • American Gene Technologies
  • Dimension Therapeutics
  • BioMarin Pharmaceutical
  • Synthetic Biologics
  • Codexis
  • SOM Innovation Biotech
  • Daiichi Sankyo
  • Erytech Pharma

Global Phenylketonuria Treatment market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Phenylketonuria Treatment market, Segment by Type:

  • Drugs
  • Dietary Supplement

Global Phenylketonuria Treatment market, by Application

  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Pediatric Clinics

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Phenylketonuria Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Phenylketonuria Treatment
1.1 Phenylketonuria Treatment Market Overview
1.1.1 Phenylketonuria Treatment Product Scope
1.1.2 Phenylketonuria Treatment Market Status and Outlook
1.2 Global Phenylketonuria Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Phenylketonuria Treatment Market Size by Region (2018-2029)
1.4 Global Phenylketonuria Treatment Historic Market Size by Region (2018-2023)
1.5 Global Phenylketonuria Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Phenylketonuria Treatment Market Size (2018-2029)
1.6.1 North America Phenylketonuria Treatment Market Size (2018-2029)
1.6.2 Europe Phenylketonuria Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Phenylketonuria Treatment Market Size (2018-2029)
1.6.4 Latin America Phenylketonuria Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Phenylketonuria Treatment Market Size (2018-2029)
2 Phenylketonuria Treatment Market by Type
2.1 Introduction
2.1.1 Drugs
2.1.2 Dietary Supplement
2.2 Global Phenylketonuria Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Phenylketonuria Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Phenylketonuria Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Phenylketonuria Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Phenylketonuria Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Phenylketonuria Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Phenylketonuria Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Phenylketonuria Treatment Revenue Breakdown by Type (2018-2029)
3 Phenylketonuria Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Drug Stores
3.1.3 Online Pharmacies
3.1.4 Pediatric Clinics
3.2 Global Phenylketonuria Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Phenylketonuria Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Phenylketonuria Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Phenylketonuria Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Phenylketonuria Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Phenylketonuria Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Phenylketonuria Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Phenylketonuria Treatment Revenue Breakdown by Application (2018-2029)
4 Phenylketonuria Treatment Competition Analysis by Players
4.1 Global Phenylketonuria Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Phenylketonuria Treatment as of 2022)
4.3 Date of Key Players Enter into Phenylketonuria Treatment Market
4.4 Global Top Players Phenylketonuria Treatment Headquarters and Area Served
4.5 Key Players Phenylketonuria Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Phenylketonuria Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 American Gene Technologies
5.1.1 American Gene Technologies Profile
5.1.2 American Gene Technologies Main Business
5.1.3 American Gene Technologies Phenylketonuria Treatment Products, Services and Solutions
5.1.4 American Gene Technologies Phenylketonuria Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 American Gene Technologies Recent Developments
5.2 Dimension Therapeutics
5.2.1 Dimension Therapeutics Profile
5.2.2 Dimension Therapeutics Main Business
5.2.3 Dimension Therapeutics Phenylketonuria Treatment Products, Services and Solutions
5.2.4 Dimension Therapeutics Phenylketonuria Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Dimension Therapeutics Recent Developments
5.3 BioMarin Pharmaceutical
5.3.1 BioMarin Pharmaceutical Profile
5.3.2 BioMarin Pharmaceutical Main Business
5.3.3 BioMarin Pharmaceutical Phenylketonuria Treatment Products, Services and Solutions
5.3.4 BioMarin Pharmaceutical Phenylketonuria Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Synthetic Biologics Recent Developments
5.4 Synthetic Biologics
5.4.1 Synthetic Biologics Profile
5.4.2 Synthetic Biologics Main Business
5.4.3 Synthetic Biologics Phenylketonuria Treatment Products, Services and Solutions
5.4.4 Synthetic Biologics Phenylketonuria Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Synthetic Biologics Recent Developments
5.5 Codexis
5.5.1 Codexis Profile
5.5.2 Codexis Main Business
5.5.3 Codexis Phenylketonuria Treatment Products, Services and Solutions
5.5.4 Codexis Phenylketonuria Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Codexis Recent Developments
5.6 SOM Innovation Biotech
5.6.1 SOM Innovation Biotech Profile
5.6.2 SOM Innovation Biotech Main Business
5.6.3 SOM Innovation Biotech Phenylketonuria Treatment Products, Services and Solutions
5.6.4 SOM Innovation Biotech Phenylketonuria Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 SOM Innovation Biotech Recent Developments
5.7 Daiichi Sankyo
5.7.1 Daiichi Sankyo Profile
5.7.2 Daiichi Sankyo Main Business
5.7.3 Daiichi Sankyo Phenylketonuria Treatment Products, Services and Solutions
5.7.4 Daiichi Sankyo Phenylketonuria Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Daiichi Sankyo Recent Developments
5.8 Erytech Pharma
5.8.1 Erytech Pharma Profile
5.8.2 Erytech Pharma Main Business
5.8.3 Erytech Pharma Phenylketonuria Treatment Products, Services and Solutions
5.8.4 Erytech Pharma Phenylketonuria Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Erytech Pharma Recent Developments
6 North America
6.1 North America Phenylketonuria Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Phenylketonuria Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Phenylketonuria Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Phenylketonuria Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Phenylketonuria Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Phenylketonuria Treatment Market Dynamics
11.1 Phenylketonuria Treatment Industry Trends
11.2 Phenylketonuria Treatment Market Drivers
11.3 Phenylketonuria Treatment Market Challenges
11.4 Phenylketonuria Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock